The University of Chicago Header Logo

Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer.

Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer. J Carcinog. 2008; 7:9.

View in: PubMed